270 related articles for article (PubMed ID: 6146516)
1. Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production.
Shulkin BL; Peele ME; Utiger RD
Endocrinology; 1984 Sep; 115(3):858-61. PubMed ID: 6146516
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by propranolol of 3,5,3'-triiodothyronine formation from thyroxine in isolated rat renal tubules: an effect independent of beta-adrenergic blockade.
Heyma P; Larkins RG; Campbell DG
Endocrinology; 1980 May; 106(5):1437-41. PubMed ID: 6102511
[TBL] [Abstract][Full Text] [Related]
3. Effect of different beta-blocking drugs and adrenaline on the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes.
Aanderud S; Aarbakke J; Sundsfjord J
Horm Metab Res; 1986 Feb; 18(2):110-3. PubMed ID: 2870969
[TBL] [Abstract][Full Text] [Related]
4. beta-Adrenoceptor antagonists: new drugs and new indications.
Koch-Weser J; Frishman WH
N Engl J Med; 1981 Aug; 305(9):500-6. PubMed ID: 6114433
[No Abstract] [Full Text] [Related]
5. Comparative review of beta-blocking agents.
Jackson EA; Sullman SA
Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
[No Abstract] [Full Text] [Related]
6. Class III action of beta-blocking agents.
Taggart P; Donaldson R; Abed J; Nashat F
Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
[TBL] [Abstract][Full Text] [Related]
7. The new beta-adrenergic antagonists.
Chung DC; Laschuk MJ
Can Anaesth Soc J; 1984 Jul; 31(4):430-3. PubMed ID: 6146393
[No Abstract] [Full Text] [Related]
8. The effect of D,L-4-hydroxypropranolol on the thyroxine to 3,5,3'-triiodothyronine conversion in rat renal and liver microsomes.
Jørgensen PH; Lumholtz IB; Faber J; Kirkegaard C; Siersbaek-Nielsen K; Friis T
Acta Endocrinol (Copenh); 1984 Feb; 105(2):205-10. PubMed ID: 6695551
[TBL] [Abstract][Full Text] [Related]
9. Central propranolol and pindolol, but not atenolol nor metoprolol, inhibit sexual behavior in male rats.
Smith ER; Kacker SR; Raskin A; Yun PT; Davidson JM; Hoffman BB; Clark JT
Physiol Behav; 1996 Feb; 59(2):241-6. PubMed ID: 8838601
[TBL] [Abstract][Full Text] [Related]
10. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Patterson E; Lucchesi BR
Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
[TBL] [Abstract][Full Text] [Related]
11. β
Lima AT; Amorim AC; Britto-Júnior J; Campitelli RR; Fregonesi A; Mónica FZ; Antunes E; De Nucci G
Naunyn Schmiedebergs Arch Pharmacol; 2022 Oct; 395(10):1257-1268. PubMed ID: 35798982
[TBL] [Abstract][Full Text] [Related]
12. Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects.
Harvengt C; Heller FR; Martiat P; Van Nieuwenhuyze Y
J Clin Pharmacol; 1987 Jul; 27(7):475-80. PubMed ID: 2888790
[TBL] [Abstract][Full Text] [Related]
13. [Beta-blockers and migraine].
Massiou H; Bousser MG
Pathol Biol (Paris); 1992 Apr; 40(4):373-80. PubMed ID: 1353872
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
15. Interaction of beta adrenergic agonists and antagonists with brain beta adrenergic receptors in vivo.
Conway PG; Tejani-Butt S; Brunswick DJ
J Pharmacol Exp Ther; 1987 Jun; 241(3):755-62. PubMed ID: 2885407
[TBL] [Abstract][Full Text] [Related]
16. Triiodothyronine production by isolated rat hepatocytes: characterization and lack of glucoregulatory hormone effects.
Utiger RD
Horm Metab Res; 1984 Dec; 16 Suppl 1():28-31. PubMed ID: 6398264
[TBL] [Abstract][Full Text] [Related]
17. Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.
Perrild H; Hansen JM; Skovsted L; Christensen LK
Clin Endocrinol (Oxf); 1983 Feb; 18(2):139-42. PubMed ID: 6133659
[TBL] [Abstract][Full Text] [Related]
18. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
[TBL] [Abstract][Full Text] [Related]
19. Effect of hypothyroidism and hyperthyroidism on triiodothyronine production in perfused rat liver.
Jennings AS; Crutchfield FL; Dratman MB
Endocrinology; 1984 Mar; 114(3):992-7. PubMed ID: 6697973
[TBL] [Abstract][Full Text] [Related]
20. Are beta-adrenergic mechanisms involved in ocular hypotensive actions of adrenergic drugs?
Chiou GC; Watanabe K; McLaughlin MA; Liu HK
Ophthalmic Res; 1985; 17(1):49-53. PubMed ID: 2858837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
